Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer Stage IV”

217 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 217 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03854474
What this trial is testing

Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma

Who this might be right for
Locally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaStage III Bladder Cancer AJCC v8+1 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Testing effectiveness (Phase 2)Ended earlyNCT04039867
What this trial is testing

Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

Who this might be right for
Carcinoma, Transitional Cell
University of California, Irvine 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT00365157
What this trial is testing

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

Who this might be right for
Advanced Urothelial CarcinomaLocally Advanced Urothelial CarcinomaMetastatic Urothelial Carcinoma+4 more
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Study completedNCT00186277
What this trial is testing

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
Stanford University 10
Testing effectiveness (Phase 2)Study completedNCT00461851
What this trial is testing

Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma

Who this might be right for
Bladder Cancer
Yale University 17
Large-scale testing (Phase 3)Looking for participantsNCT05987241
What this trial is testing

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaMuscle Invasive Renal Pelvis Urothelial CarcinomaMuscle Invasive Ureter Urothelial Carcinoma+4 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT01821105
What this trial is testing

2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV A Bladder Cancer+3 more
Ohio State University Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT01118039
What this trial is testing

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Hospital del Mar 41
Large-scale testing (Phase 3)Study completedNCT00028756
What this trial is testing

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

Who this might be right for
Stage III Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder
European Organisation for Research and Treatment of Cancer - EORTC 285
Testing effectiveness (Phase 2)Ended earlyNCT00087295
What this trial is testing

S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 6
Not applicableEnded earlyNCT01954173
What this trial is testing

Adjuvant Radiation for High Risk Bladder Cancer

Who this might be right for
Bladder CancerSquamous Cell Carcinoma of the BladderStage III Bladder Cancer+2 more
Emory University 19
Not applicableWithdrawnNCT02944357
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaStage III Bladder Urothelial Carcinoma+1 more
Mayo Clinic
Not applicableStudy completedNCT00900276
What this trial is testing

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

Who this might be right for
Bladder CancerKidney CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more
Wake Forest University Health Sciences 5
Load More Results
992